Trial
NCT04908735
Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Children's Hospital Medical Center, Cincinnati
Collaborators
—
Condition
Hematopoietic Stem Cell Transplant (HSCT)
Intervention
Ruxolitinib
Why stopped
Study closed due to slow enrollment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2026-04-07